These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 810065)
1. Syndrome of the defective lysosome--the genetic mucopolysaccharidoses. Rennert OM Ann Clin Lab Sci; 1975; 5(5):355-62. PubMed ID: 810065 [TBL] [Abstract][Full Text] [Related]
2. The mucopolysaccharidoses: a success of molecular medicine. Clarke LA Expert Rev Mol Med; 2008 Jan; 10():e1. PubMed ID: 18201392 [TBL] [Abstract][Full Text] [Related]
3. The mucopolysaccharidoses and mucolipidoses as model systems for the investigation of genetic disorders. Shapiro LJ Birth Defects Orig Artic Ser; 1981; 17(2):191-203. PubMed ID: 6461367 [No Abstract] [Full Text] [Related]
4. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses. Wegrzyn G; Wegrzyn A; Tylki-Szymańska A Med Hypotheses; 2004; 62(6):986-92. PubMed ID: 15142662 [TBL] [Abstract][Full Text] [Related]
7. Replacement of genotype-specific proteins in mucopolysaccharidoses. Neufeld EF Birth Defects Orig Artic Ser; 1973 Mar; 9(2):27-30. PubMed ID: 4279710 [No Abstract] [Full Text] [Related]
8. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know. Filocamo M; Tomanin R; Bertola F; Morrone A Ital J Pediatr; 2018 Nov; 44(Suppl 2):129. PubMed ID: 30442161 [TBL] [Abstract][Full Text] [Related]
9. [Achievements of biochemical genetics in studying hereditary pathology of the connective tissue]. Krasnopol'skaia KD Vestn Akad Med Nauk SSSR; 1982; (6):70-6. PubMed ID: 6810573 [No Abstract] [Full Text] [Related]
10. [Characteristics of intracellular and excretory glycosaminoglycans in hereditary mucopolysaccharidoses]. Odinokova ON; Bialik MA; Krasnopol'skaia KD; Iakovlev SA Vopr Med Khim; 1986; 32(1):87-92. PubMed ID: 3082072 [TBL] [Abstract][Full Text] [Related]
12. [Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis]. Malm G; Bondeson ML; von Döbeln U; Månsson JE Lakartidningen; 2002 Apr; 99(16):1804-9. PubMed ID: 12043480 [TBL] [Abstract][Full Text] [Related]
13. Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. Leal AF; Benincore-Flórez E; Rintz E; Herreño-Pachón AM; Celik B; Ago Y; Alméciga-Díaz CJ; Tomatsu S Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613919 [TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and diagnosis of mucopolysaccharidoses. Stapleton M; Arunkumar N; Kubaski F; Mason RW; Tadao O; Tomatsu S Mol Genet Metab; 2018 Sep; 125(1-2):4-17. PubMed ID: 30057281 [TBL] [Abstract][Full Text] [Related]
18. Heritable disorders of mucopolysaccharide metabolism. Williams HE Calif Med; 1967 Apr; 106(4):306-11. PubMed ID: 4227712 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator. Clarke LA Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v13-8. PubMed ID: 22210665 [TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement therapy in the mucopolysaccharidoses by fibroblast transplantation. Dean MF; Muir H; Benson P; Button L Birth Defects Orig Artic Ser; 1980; 16(1):445-56. PubMed ID: 6778531 [No Abstract] [Full Text] [Related] [Next] [New Search]